Home / NEWBRY.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does NEWBRY.ST make money? Does NEWBRY.ST have pricing power? What's the Earnings Whisper? Will NEWBRY.ST profit more as the business scales? What is NEWBRY.ST's management track record? Is NEWBRY.ST's current price justified?

Newbury Pharmaceuticals AB (publ)

SEK 1.62 +$0.40 (+32.79%)

STO · 30 Oct 2026 11:37 UTC

Previous Close

SEK 1.58

Day Range

SEK 1.60SEK 1.64

Year Range

SEK 0.76SEK 7.88

Market Cap

49.24M

AVG Volume

46.67K

Trailing/Forward PE

-2.19/-

PEG ratio

-0.01

Dividend Yield

Next Earnings Date

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · Q

NEWBRY.ST Revenue (SEK) by quarter
Period	Revenue (SEK)
26 Q4	13.58M
26 Q3	8.93M
26 Q2	8.45M
26 Q1	11.72M
25 Q4	-25.66M
25 Q3	6.69M
25 Q2	12.43M
25 Q1	6.54M
24 Q4	21.12M
24 Q3	1.39M

Net Income (SEK) · Q

NEWBRY.ST Net Income (SEK) by quarter
Period	Net Income (SEK)
26 Q4	-6.83M
26 Q3	-5.01M
26 Q2	-4.56M
26 Q1	-6.53M
25 Q4	-7.54M
25 Q3	-6.58M
25 Q2	-1.85M
25 Q1	-4.64M
24 Q4	1.74M
24 Q3	-8.66M

Operating Income (SEK) · Q

NEWBRY.ST Operating Income (SEK) by quarter
Period	Operating Income (SEK)
26 Q4	-6M
26 Q3	-4.39M
26 Q2	-4.14M
26 Q1	-6.12M
25 Q4	-8.77M
25 Q3	-6.17M
25 Q2	-1.44M
25 Q1	-4.23M
24 Q4	1.9M
24 Q3	-8.3M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (SEK) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Newbury Pharmaceuticals AB (publ)

Earnings: NEWBRY.ST

Video analysis: NEWBRY.ST

News: NEWBRY.ST

Similar companies